These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

506 related items for PubMed ID: 17698262

  • 1. Plasmid DNA and viral vector-based vaccines for the treatment of cancer.
    Anderson RJ, Schneider J.
    Vaccine; 2007 Sep 27; 25 Suppl 2():B24-34. PubMed ID: 17698262
    [Abstract] [Full Text] [Related]

  • 2. Recombinant viral vectors: cancer vaccines.
    Harrop R, John J, Carroll MW.
    Adv Drug Deliv Rev; 2006 Oct 01; 58(8):931-47. PubMed ID: 17030074
    [Abstract] [Full Text] [Related]

  • 3. Live attenuated bacteria as vectors to deliver plasmid DNA vaccines.
    Dietrich G, Spreng S, Favre D, Viret JF, Guzman CA.
    Curr Opin Mol Ther; 2003 Feb 01; 5(1):10-9. PubMed ID: 12669465
    [Abstract] [Full Text] [Related]

  • 4. Vaccine delivery methods using viral vectors.
    Bråve A, Ljungberg K, Wahren B, Liu MA.
    Mol Pharm; 2007 Feb 01; 4(1):18-32. PubMed ID: 17274663
    [Abstract] [Full Text] [Related]

  • 5. Plasmid DNA- and messenger RNA-based anti-cancer vaccination.
    Weide B, Garbe C, Rammensee HG, Pascolo S.
    Immunol Lett; 2008 Jan 15; 115(1):33-42. PubMed ID: 18006079
    [Abstract] [Full Text] [Related]

  • 6. [New advances in clinical trials of cancer vaccines].
    Peng F, Wei YQ.
    Ai Zheng; 2006 Aug 15; 25(8):1059-62. PubMed ID: 16965694
    [Abstract] [Full Text] [Related]

  • 7. DNA vaccines--challenges in delivery.
    Pachuk CJ, McCallus DE, Weiner DB, Satishchandran C.
    Curr Opin Mol Ther; 2000 Apr 15; 2(2):188-98. PubMed ID: 11249641
    [Abstract] [Full Text] [Related]

  • 8. DNA vaccines: vector design, delivery, and antigen presentation.
    Feltquate DM.
    J Cell Biochem Suppl; 1998 Apr 15; 30-31():304-11. PubMed ID: 9893284
    [Abstract] [Full Text] [Related]

  • 9. Optimization and delivery of plasmid DNA for vaccination.
    Jechlinger W.
    Expert Rev Vaccines; 2006 Dec 15; 5(6):803-25. PubMed ID: 17184219
    [Abstract] [Full Text] [Related]

  • 10. Non-viral vector as vaccine carrier.
    Chen WC, Huang L.
    Adv Genet; 2005 Dec 15; 54():315-37. PubMed ID: 16096017
    [Abstract] [Full Text] [Related]

  • 11. Chemical adjuvants for plasmid DNA vaccines.
    Greenland JR, Letvin NL.
    Vaccine; 2007 May 10; 25(19):3731-41. PubMed ID: 17350735
    [Abstract] [Full Text] [Related]

  • 12. DNA vaccines for cancer.
    Boyd D, Hung CF, Wu TC.
    IDrugs; 2003 Dec 10; 6(12):1155-64. PubMed ID: 14666426
    [Abstract] [Full Text] [Related]

  • 13. DNA vaccines for biodefence.
    Garmory HS, Perkins SD, Phillpotts RJ, Titball RW.
    Adv Drug Deliv Rev; 2005 Jun 17; 57(9):1343-61. PubMed ID: 15935877
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. DNA vaccination and gene therapy: optimization and delivery for cancer therapy.
    Bodles-Brakhop AM, Draghia-Akli R.
    Expert Rev Vaccines; 2008 Sep 17; 7(7):1085-101. PubMed ID: 18767956
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Technological advances to increase immunogenicity of DNA vaccines.
    Lemieux P.
    Expert Rev Vaccines; 2002 Jun 17; 1(1):85-93. PubMed ID: 12908515
    [Abstract] [Full Text] [Related]

  • 18. [Advances in the researches of DNA vaccines against tumors].
    Lu Y, Tian L, Wei Y, Yang L, Zhao X.
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2000 Aug 17; 17(4):288-90. PubMed ID: 10932018
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Fowlpox virus as a recombinant vaccine vector for use in mammals and poultry.
    Skinner MA, Laidlaw SM, Eldaghayes I, Kaiser P, Cottingham MG.
    Expert Rev Vaccines; 2005 Feb 17; 4(1):63-76. PubMed ID: 15757474
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.